In the March issue of CRfocus, Danielle Jacobs provides essential advice for those setting up new clinical research departments (and useful reminders for the rest of us) on
common mistakes and pitfalls encountered by start-up companies, and (thankfully) how to avoid them.
Tim Ewbank of Harten Group presents the results of their
2009/10 survey of executive confidence around the pharma and biotech sector, finding that 2009 wasn't quite as bad as some had feared it would be, that the concerns and interests of pharma and biotech companies are continuing to converge, but that the issue of the viability of clinical research in the UK still remains unanswered. Lynn Seeley explains some of the key differences for
a monitor
working in a non-commercial setting compared with the type of
activities carried out by a CRA in a commercial organisation.
Also in this issue, we
interview Raj Parekh, who will be discussing the current state
of venture capital in the life sciences at
ICR's 2010 Annual Conference, Philippa Smit-Marshall provides an
update from ICR's Paediatrics Advisory Group, and Jane Barrett
reviews the book "Healthcare research, ethics and law" by Hazel Biggs.
About CRfocus
Clinical Research focus (CRfocus) is ICR's peer-reviewed journal, published every month. CRfocus publishes authoritative articles to keep readers up to date with best practice, and develop their careers. Members of ICR receive CRfocus free of charge; non-members can subscribe for £135 per year